| Jeffery John Guajardo, APRN, BC | |
|
6216 Airpark Dr, Chattanooga, TN 37421-2988 | |
| (423) 899-0024 | |
| (423) 899-5688 |
| Full Name | Jeffery John Guajardo |
|---|---|
| Gender | Male |
| Speciality | Clinical Nurse Specialist - Psychiatric/mental Health, Adult |
| Location | 6216 Airpark Dr, Chattanooga, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063433944 | NPI | - | NPPES |
| 2255114 | Other | TN | CIGNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0809X | Clinical Nurse Specialist - Psychiatric/mental Health, Adult | APN0000011557 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jeffery John Guajardo, APRN, BC 6216 Airpark Dr, Chattanooga, TN 37421-2988 Ph: () - | Jeffery John Guajardo, APRN, BC 6216 Airpark Dr, Chattanooga, TN 37421-2988 Ph: (423) 899-0024 |
News Archive
Mathematical models analyzing how a cholera outbreak spread in Zimbabwe are providing new insights into the most effective vaccination strategies for preventing future cholera epidemics, according to University of Florida researchers.
When we move, we rarely move in the exact same way twice. The National Science Foundation has awarded Carnegie Mellon University Assistant Professor of Biomedical Engineering Steven Chase and Associate Professor of Electrical and Computer Engineering and Biomedical Engineering Byron Yu, and their long-time collaborator, University of Pittsburgh Associate Professor of Bioengineering Aaron Batista, an $869,000 grant to conduct basic research that will establish how variability in movement is encoded in the brain and how this variability contributes to learning and performance.
A new evidence review finds that ridding homes and offices of mold and dampness can help reduce respiratory infections and troubling symptoms for asthma sufferers across the globe; however, the best way to eliminate the mold remains unclear.
Marcadia Biotech Inc. today announced that it has initiated a Phase 1 clinical trial of MAR701, a novel dual agonist of the incretin hormone receptors for glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Marcadia plans to initially develop this compound as a treatment for type 2 diabetes with once-weekly dosing. The Phase 1 trial will evaluate MAR701 in healthy volunteers at escalating dose levels.
› Verified 2 days ago
Ms. Joyce A Beardsley, NP Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 2501 Citico Ave, Chattanooga, TN 37404 Phone: 423-697-2000 Fax: 423-697-2118 | |
Mrs. Brooke Spencer Henson, MSN, APRN, FNP-C Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 7405 Shallowford Rd Ste 160, Chattanooga, TN 37421 Phone: 423-899-1000 | |
Mrs. Lena Michelle Patterson, APN, CCNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 2501 Citico Ave, Chattanooga, TN 37404 Phone: 423-697-2000 Fax: 423-697-2118 | |
Mrs. Minnie Bernice Troupe, APN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 100 Moccasin Bend Rd, Chattanooga, TN 37405 Phone: 423-265-2271 Fax: 423-785-3305 | |
Holly Wells, NNP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 975 E 3rd St, Box 159, Chattanooga, TN 37403 Phone: 423-778-6170 | |
Ms. Carol Orr, CNS/APN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 601 Cumberland St, Helen Ross Mcnabb Center, Chattanooga, TN 37404 Phone: 423-266-6751 |